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Abstract
Purpose Exercise can help cancer survivors manage sequela, treatment side effects, improve overall quality of life, and
is recommended for most. The purpose of this study was to investigate exercise behavior and factors influencing exercise
engagement among cancer survivors at the National Cancer Centre, Singapore (NCCS).
Methods This cross-sectional study was inclusive of survivors of all cancer types and stages who were at least 21 years
of age and had undergone chemotherapy at the NCCS. Surveys were utilized to assess survivor barriers and facilitators to
exercise and to retrospectively assess physical activity and exercise behaviors at 4 cancer-related time periods (pre-diagnosis
and post-diagnosis before, during, or after chemotherapy).
Results A total of 102 cancer survivors were enrolled; 60% were diagnosed with stage IV cancer. Predominant cancer types
included lower gastrointestinal tract (25.5%) and breast cancer (21.6%). Prior to cancer diagnosis, 90.2% of participants
reported aerobic activity satisfying NCCN guidelines. Significant reductions in reported exercise, and physical activity, were
observed following cancer diagnosis that persisted during chemotherapy. Key exercise facilitators included the desire to
remain healthy (86.3%) and to improve sleep and mental well-being (73.5%). Key barriers included side effects of treatment
(52.0%). Only 46.1% of survivors reported receiving exercise guidance from healthcare professionals following diagnosis.
Conclusion Overall, even among this notably active cohort of Singaporean survivors, opportunities for increased exercise
engagement throughout the survivorship continuum remain. Increased education regarding the benefits of exercise to survivors as well as guidance regarding exercise modalities including resistance training is greatly needed as well.
Keywords Oncology · Exercise · Cancer survivorship · Counseling · Barriers · Facilitators
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Introduction
Advancements in cancer detection and treatment have led
to decreased cancer mortality rates and a rapidly increasing
population of cancer survivors with unique survivorship needs
[1]. Cancer survivors, defined by the National Comprehensive
Cancer Network (NCCN) as individuals from cancer diagnosis through end of life, often experience reduced quality of
life (QoL) due the physiological and psychosocial side effects
associated with cancer and its treatments. Prevalent sequelae
and side effects include cancer-related fatigue, pain, depression, cognitive difficulties, and sleep disruption that often
persist years after treatment completion, in addition to treatment-related comorbidities including cardiovascular disease
and type II diabetes [2–4]. The prevalence of serious and often
long-term morbidities among survivors, especially those who
have undergone chemotherapy, highlights the critical need for
effective interventions. One promising intervention of growing interest is exercise.
A growing body of evidence has determined exercise
to be a promising intervention for managing the adverse
effects of cancer and its treatments, with benefits including improved physical function, cardiorespiratory fitness,
cancer-related fatigue, psychosocial well-being, and body
composition [5–7]. Further, exercise has been associated
with an increased tolerance for cancer medication, reduced
risk of cancer recurrence, reduced all-cause mortality, as
well as reduced breast, colon, and prostate cancer-specific
mortalities [8–10]. Clear and consistent evidence aided
in the development of survivor-specific exercise guidelines, the earliest of which recommended at least 150 min
of moderate-intensity or 75 min of vigorous-intensity of
aerobic exercise per week along with structured resistance
training [6, 11, 12]. However, these guidelines have since
been updated to be individualized, prescriptive, and less
concerned with arbitrary targets [11, 13–15]. Under current guidelines, each individual cancer survivor is recommended to be screened and assessed for sequelae, comorbidities, prior activity levels, and personal goals in order
to inform the selection of the appropriate exercise dose,
frequency, and modality [6, 11, 13–17].
Despite the abundance of evidence and detailed guidelines, most cancer survivors are not meeting exercise guideline recommendations [4, 12, 18–22]. Preliminary explorations into this phenomena have determined that oncology
health care professionals (HCPs) often have limited awareness of exercise guidelines and report feeling underqualified to provide exercise guidance to survivors [13, 18, 22].
However, oncology HCPs have also expressed understanding
exercise as an important component of survivorship care, as
well as interest in receiving further education and multidisciplinary team support to address this cancer survivorship need
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[13, 18]. To date, preliminary investigations into facilitators
and barriers of exercise for cancer survivors have been conducted in cohorts from countries including the USA, Australia, Norway, Korea, Canada, and the UK [20, 22–25] that
are predominantly western civilizations with the exception of
Korea. Survivor-specific barriers to exercise identified among
these cohorts have included lack of time, fatigue, treatmentrelated side effects, and lack of education regarding exercise
recommendations and benefits [13, 18, 22]. Key facilitators
have included the ability to regain an aspect of control over
one’s health and mental wellbeing [22]. However, culture has
a profound influence on health behaviors and existing findings may have limited generalizability to cancer survivors in
Singapore.
Cancer survivorship care in Singapore is in its early stages
[26]. Historically, Singapore’s approach to cancer survivorship has been surveillance-focused and oncologist-centric, in
contrast to the shared-care models of survivorship care often
seen in North American and European countries [26, 27]. With
a rising prevalence of survivors and recognition of structural
changes needed to meet growing national survivorship needs,
Singapore held its first cancer supportive and survivorship
care forum in December of 2016. Several key principles for
the nationwide improvement of cancer survivorship care were
identified including the necessity of a survivor-centered focus,
integrated and coordinated care, and a strong research infrastructure for the development of evidence-based programs
[26]. In accordance with forum findings, the National Cancer Center, Singapore (NCCS) began the development of a
new center dedicated to meeting the needs of Singapore’s
constantly growing cancer survivor population. A key area of
interest for the new center is the implementation of evidencebased interventions to manage poorly understood survivorship issues, including standardized and structured exercise
programs. However, there is a dearth of research regarding
survivor exercise engagement and factors influencing engagement in Singapore that would be critical to the development
and implementation of an effective exercise program for this
unique population. Therefore, this study was broadly designed
to (1) investigate barriers and facilitators to exercise among
Singaporean cancer survivors who are undergoing, or have
undergone, chemotherapy at the NCCS and to (2) assess Singaporean cancer survivors’ exercise behaviors across the survivorship continuum.

Methods
Study design
This cross-sectional study was conducted at the NCCS
between August and October 2019. The NCCS is the largest
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ambulatory cancer center in Singapore, treating up to 70%
of all adult cancer patients. Ethics approval was granted by
SingHealth Centralised Institutional Review Board (CIRB
Ref: 2019/2528) prior to study commencement.

Inclusion and exclusion criteria
This study recruited cancer survivors who were at least
21 years old, able to read and understand English, diagnosed
with any cancer of any stage (I–IV) by an oncologist, and
who had received chemotherapy at the NCCS within the past
12 months prior to study enrollment. Cancer survivors were
excluded if they had cognitive or severe psychiatric disorders
that investigators judged to likely impair their ability to provide informed consent or answer questionnaires.

Study procedures
Survivors at the NCCS were identified by their oncologist,
approached during either a routine chemotherapy session or
consultation visit and screened for eligibility. Survivors who
consented to participate were given a set of self-administered
survey questionnaires in English which were collected upon
completion. Each set of questionnaires took approximately
20–30 min to complete.

Measures
Demographic and clinical information
Demographic information (age, gender, height and weight,
ethnicity, education, marital status, and employment status) and clinical information (cancer type, stage of cancer,
Eastern Cooperative Oncology Group (ECOG) performance
status, comorbidities, cancer treatments received, and time
since chemotherapy completion) were collected through
self-administered questionnaire.
Exercise and physical activity behaviors
Exercise and physical activity behavior were assessed
through an investigator-designed recall questionnaire. Survivors were asked to classify weekly activity into two categories: exercise or physical activity. Exercise was defined
as purposeful, prescriptive, programmed, and progressive
activities of a specific nature [28]. Physical activity and
exercise were further categorized into 3 levels of intensity:
light (no noticeable change in breathing pattern), moderate
(breath quickens but not out of breath, develop light sweat
after approximately 10 min, can talk but cannot sing), and
vigorous (breathing is deep and rapid, develop sweat after

several minutes, cannot say a few words without stopping
to catch a breath) [11]. Survivors were asked to recall their
exercise and physical activity behavior at each intensity level
across four different cancer-related time periods: (1) prediagnosis, (2) post-diagnosis before chemotherapy, (3) during chemotherapy, and (4) post-chemotherapy. Post-chemotherapy activity was reported only by participants who had
completed chemotherapy at the time of study participation.
Information on activity type (walking, cycling, housework,
etc.) and estimated weekly duration was collected in freeform text.
Perceived exercise barriers and facilitators
Cancer survivors’ perceived barriers and facilitators to exercise were assessed using an investigator-designed questionnaire containing 20 barriers and 15 facilitators selected a
priori based on findings from existing literature [20, 22–25,
29]. Participants were asked to select each facilitator and
barrier they believed influenced their exercise behavior.
Exercise guidance and education
History of exercise education and guidance provision
was assessed using 5 conditional, closed-ended questions
(Fig. 1). Participants were asked whether they had previous
exposure to information regarding exercise and cancer, were
advised to exercise by a HCP (e.g., oncologist, physiotherapist, social worker) or fitness professional (e.g., personal
trainer, instructor) following cancer diagnosis, and whether
this information had been adequate to motivate them to initiate exercise. Finally, participant interest in a guided exercise program designed by study investigators for potential
implementation at the new NCCS facility was assessed. This
program was described as 3, 50-min sessions per week on a
stationary bicycle: one supervised at a rehabilitation center
and 2 unsupervised at home.

Statistical analysis
Statistical analyses were performed in SAS 9.3 (SAS Institute, Cary, NC). Descriptive statistics were used to describe
demographic, clinical, and survey data. Categorical variables were presented as proportions and continuous variables were summarized as mean, standard deviation (SD), and
range. For the purposes of data analysis, participants were
divided into two subgroups: (1) those who were undergoing
chemotherapy at the time of participation and (2) those who
had completed therapy treatment at the time of participation. Differences between subgroups were assessed using
chi-square tests for categorical demographic and clinical
variables. Fisher’s exact tests were used when cell counts
were below 5. Independent t-tests were used to compare age
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Fig. 1  Survivor exercise guidance and education survey

(n = 102)
Question 1. Have you seen, heard or read anything relating to cancer and exercise?
Yes (n = 75)
•
•
•
•
•
•

73.3% HCPs
45.3% family/friends
41.3% internet
26.7% media
0.04% fitness professionals
2.7% traditional Chinese medicine

Question 2. Have you been advised to exercise by healthcare professionals/ fitness professionals
during/after cancer treatment?
Yes (n = 47)
Yes
(n = 47)
Question 3. Was the advice from healthcare professionals/fitness
professionals adequate in getting you to start exercising?
Yes (n = 34), and this successful advice was given by
• 79.4% physician
• 41.2% nurse
• 23.5% physiotherapist
• 2.9% fitness professional
• 2.9% pharmacist
• 2.9% psychologist

No

Yes
(n = 102)
Question 5. Would you like to participate in a guided exercise program designed by healthcare
professionals that involves 3 exercise sessions a week using a stationary bicycle. Each session will be
50 minutes in length, one session will be supervised at a rehabilitation center and the other 2 sessions
will be unsupervised and done at your home.
Yes (n = 50)

and body mass index (BMI) following confirmation of normality through QQ-plots. Differences between subgroups
in the proportion of participants reporting each individual
facilitator and barrier were compared using chi-square tests.
Self-reported weekly duration of physical activity and exercise were summarized as median and interquartile range
(IQR). Wilcoxon signed-rank test was used to test for differences in activity levels at each timepoint compared to
activity levels prior to cancer diagnosis. Additionally, the
proportion of respondents meeting NCCN cancer survivorship aerobic exercise guidelines at each time period was
assessed. McNemar’s test for paired samples was utilized to
compare the proportion of participants meeting guidelines
at each timepoint to the proportion meeting guidelines prior
to cancer diagnosis. A p value less than 0.05 was considered
statistically significant.
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Results
Demographic and clinical characteristics
A total of 221 survivors were identified and approached for
participation in this study. Of the 221, 202 were confirmed to
meet eligibility criteria and 102 (50.5%) consented to participate. Of the 102 study participants, 65 (63.7%) were undergoing chemotherapy at the time participation and 37 (36.3%)
had completed chemotherapy. Participants were primarily
Chinese (84.3%), male (52.9%), married (72.5%), graduates/post-graduates (38.2%), and not working at the time
of participation (43.1%) (Table 1). The mean (± SD) age of
participants was 54.6 ± 12.7 and the mean (± SD) BMI was
23.1 ± 4.0. Thirty-nine respondents (38.2%) reported additional comorbidities, including hypertension (17.6%), diabetes (15.7%), and high cholesterol (13.7%). No significant
differences in demographic characteristics between participants undergoing chemotherapy at the time of participation
and those who had completed chemotherapy were observed.
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Table 1  Demographic and clinical characteristics of study participants
Undergoing chemotherapy
(N = 65)
Demographic characteristics
Gender
Male
Female
Race
Chinese
Malay
Indian
Other
Marital status
Married
Single
Divorced
Widowed
Living alone
No
Yes
Education level
Primary
Secondary
Pre-university
Graduate/post-graduate
Employment status
Not working
Full-time employment
Part-time employment
Self-employed
Age (years): mean ± SD (range)
Clinical characteristics
Cancer type
Lower gastrointestinal tract
Breast
Hematologic malignancies
Head and neck
Female reproductive organs
Hepatobiliary system
Upper gastrointestinal tract
Thorax
Genitourinary cancers
Soft tissue sarcoma
Cancer stage
I
II
III
IV
Not applicable b

Completed chemotherapy
(N = 37)

All survivors
(N = 102)
N (%)

36 (55.4)
29 (44.6)

18 (48.6)
19 (51.4)

54 (52.9)
48 (47.1)

53 (81.5)
6 (9.2)
4 (6.2)
2 (3.1)

33 (89.2)
2 (5.4)
1 (2.7)
1 (2.7)

86 (84.3)
8 (7.8)
5 (4.9)
3 (2.9)

48 (73.8)
11 (16.9)
5 (7.7)
1 (1.5)

26 (70.3)
8 (21.6)
3 (8.1)
0 (0.0)

74 (72.5)
19 (18.6)
8 (7.8)
1 (1.0)

58 (89.2)
7 (10.8)

30 (81.1)
7 (18.9)

88 (86.3)
14 (13.7)

13 (12.7)
30 (29.4)
20 (19.6)
39 (38.2)

4 (10.8)
10 (27.0)
6 (16.2)
17 (45.9)

9 (13.8)
20 (30.8)
14 (21.5)
22 (33.8)

44 (43.1)
42 (41.2)
9 (8.8)
7 (6.9)
54.0 ± 12.6 (21–86)

14 (37.8)
18 (48.6)
1 (2.7)
4 (10.8)
55.8 ± 12.9 (31–84)

44 (43.1)
42 (41.2)
9 (8.8)
7 (6.9)
54.6 ± 12.7 (21–86)

19 (29.2)
15 (23.1)
2 (3.1)
9 (13.8)
4 (6.2)
5 (7.7)
4 (6.2)
4 (6.2)
1 (1.5)
2 (3.1)

7 (18.9)
7 (18.9)
7 (18.9)
0 (0.0)
4 (10.8)
3 (8.1)
3 (8.1)
2 (5.4)
3 (8.1)
1 (2.7)

26 (25.5)
22 (21.6)
9 (8.8)
9 (8.8)
8 (7.8)
8 (7.8)
7 (6.9)
6 (5.9)
4 (3.9)
3 (2.9)

4 (6.2)
6 (9.2)
12 (18.5)
43 (66.2)
0 (0.0)

6 (16.2)
6 (16.2)
9 (24.3)
15 (40.5)
1 (2.7)

10 (9.8)
12 (11.8)
21 (20.6)
58 (56.9)
1 (1.0)

p valuea

0.512

0.875

0.926

0.250

0.699

0.173

0.493
0.036*

0.059
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Table 1  (continued)
Undergoing chemotherapy
(N = 65)

Completed chemotherapy
(N = 37)

All survivors
(N = 102)
N (%)

ECOG performance s tatusc

p valuea

0.857

0

27 (41.5)

17 (45.9)

44 (43.1)

1

36 (55.4)

19 (51.4)

55 (53.9)

2 (3.1)

1 (2.7)

3 (2.9)

65 (100.0)
35 (53.8)
15 (23.1)
9 (13.8)
3 (4.6)

37 (100.0)
27 (73.0)
8 (21.6)
8 (21.6)
6 (16.2)

102 (100.0)
62 (60.8)
23 (22.5)
17 (16.7)
9 (8.8)

0.057
0.866
0.311
0.069

11 (16.9)
11 (16.9)
8 (12.3)
3 (4.6)
2 (3.1)
1 (1.5)
1 (1.5)
1 (1.5)
1 (1.5)
1 (1.5)
3 (4.6)
23.0 ± 4.4
–

7 (18.9)
5 (13.5)
6 (16.2)
0 (0.0)
2 (5.4)
2 (5.4)
0 (0.0)
0 (0.0)
0 (0.0)
0 (0.0)
4 (10.8)
23.5 ± 3.3
4.6 ± 3.9 (0–12)

18 (17.6)
16 (15.7)
14 (13.7)
3 (2.9)
4 (3.9)
3 (2.9)
1 (1.0)
1 (1.0)
1 (1.0)
1 (1.0)
7 (6.9)d
23.1 ± 4.0 (13.1–35.7)
4.6 ± 3.9 (0–12)

0.799
0.649
0.581
0.552
0.620
0.297
1.000
1.000
1.000
1.000
0.665
0.484
–

2
Cancer treatments received
Chemotherapy
Surgery
Radiation
Targeted
Hormonal
Comorbidities
Hypertension
Diabetes
High cholesterol
Liver disease
Osteoporosis
Cardiovascular disease
Glaucoma
Lung disease
Arthritis
Kidney disease
Others
BMI: mean ± SD (range)
Time since chemotherapy completion (N = 37): mean ± SD (range)
a 2

χ test was used to test for associations between chemotherapy completion and categorical variables, Fisher’s exact tests were used when cell
counts < 5, and independent t-tests were used to test for associations between chemotherapy completion and the means of continuous variables

b
c

Cancer staging is unavailable for acute myeloid leukemia

ECOG 0 = fully active, able to carry on all pre-disease performance without restriction; ECOG 1 = restricted in physically strenuous activity but
ambulatory and able to carry out work of a light or sedentary nature, e.g., light housework and office work; ECOG 2 = ambulatory and capable
of all self-care but unable to carry out any work activities; up and about more than 50% of waking hours

d
Endometriosis (n = 1), dermatomyositis (n = 1), age-related macular degeneration on left eye (n = 1), myasthenia gravis (n = 1), thyroid (n = 1),
psoriasis (n = 1), and PCOS (n = 1)
*

p value < 0.05

Participants were primarily diagnosed with stage IV
cancer (60%). The most prevalent cancer types included
lower gastrointestinal tract (25.5%) and breast cancer
(21.6%). Participants undergoing chemotherapy at the
time of study participation had significantly higher proportions of gastrointestinal tract and head and neck cancer,
whereas participants who had completed chemotherapy
had higher proportions of hematologic malignancies and
genitourinary cancers. All participants received chemotherapy treatment, 60.8% had cancer-related surgery,
and 22.5% received radiation therapy. Regarding disease impact, 43.1% of participants were fully active and
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able to continue pre-disease activity without restriction
(ECOG score of 0), whereas 53.9% faced restrictions in
physically strenuous activities but remained ambulatory
(ECOG score of 1). Among the 37 participants who had
completed chemotherapy at the time of study participation,
the mean (± SD) time since chemotherapy completion was
4.6 ± 3.9 months.

Exercise behavior
Prior to cancer diagnosis, 90.2% of all study participants
reported physical activity and exercise satisfying NCCN
cancer survivorship aerobic exercise guidelines (Table 2).

Supportive Care in Cancer

This proportion was significantly reduced following cancer
diagnosis (69.6%, p < 0.001) and remained reduced during
chemotherapy (65.7%, p < 0.001). Among the 37 individuals who had completed chemotherapy, 75.7% met exercise
guidelines after chemotherapy completion, which was not
significantly different than the proportion in that subset who
met guidelines prior to cancer diagnosis (83.8%, p = 0.180).
Moderate-intensity aerobic exercise was the most
reported across all time periods. The median (IQR) weekly
duration of moderate-intensity aerobic exercise across all
participants decreased from 60 (0 to 157) min/week prior
to cancer diagnosis to 0 (0 to 105) min/week following
Table 2  Proportion of
respondents meeting NCCN
cancer survivorship aerobic
exercise guidelinesa across 4
cancer-related time periods

diagnosis (p < 0.001) and remained significantly lower during chemotherapy (p < 0.001) (Table 3). However, among
participants who had completed chemotherapy, the median
weekly duration of moderate-intensity aerobic exercise after
chemotherapy completion was not significantly different
than prior to diagnosis (p = 0.297). The same pattern was
observed for vigorous-intensity aerobic exercise, the median
(IQR) weekly duration decreased from 0 (0 to 25) min/week
prior to cancer diagnosis to 0 (0 to 0) min/week following diagnosis (p < 0.001), and the median weekly duration
after chemotherapy completion was not significantly different than prior to diagnosis (p = 0.539). Cancer diagnosis

Time period

All respondents
(N = 102)
N (%)

p valueb

Undergoing
chemotherapy
(n = 65)

p valueb

Completed
p valueb
chemotherapy
(N = 37)
N (%b)

Pre-diagnosis
Post-diagnosis, before
chemotherapy
During chemotherapy
Post-chemotherapyc

92 (90.2)
71 (69.6)

Ref
< 0.001

61 (93.9)
49 (75.4)

Ref
0.001

31 (83.8)
22 (59.5)

Ref
0.003

67 (65.7)
–

< 0.001
–

46 (70.8)
–

< 0.001
–

21 (56.8)
28 (75.68)

0.002
0.180

a

Meeting the aerobic activity guideline is defined as at least 150 min of moderate-intensity or 75 min of
vigorous physical activity and/or exercise per week

b

McNemar’s test for paired samples was utilized to compare proportion of participants meeting activity
guidelines at each timepoint to proportion at pre-diagnosis

c

Post-chemotherapy proportions only include respondents who have completed chemotherapy (N = 37)

Table 3  Median (IQR) reported weekly physical activity and exercise durations of participants by intensity level, across 4 cancer-related time
periods (N = 102)
Intensity

Pre-diagnosis
Duration—min/
week, median
(IQR)

Exercise
Light

0.0
(0.0–0.0)
Moderate
60.0
(0.0–157.5)
Vigorous
0.0
(0.0–25.0)
Physical activity
Light
0.0
(0.0–50.0)
Moderate
420.0
(140.0–840.0)
Vigorous
0.0
(0.0–0.0)
a
b
*

Post-diagnosis, before chemotherapy
p valuea

Duration—min/
week, median
(IQR)

Ref

0.0
(0.0–0.0)
0.0
(0.0–105.0)
0.0
(0.0–0.0)

Ref
Ref

Ref
Ref
Ref

0.0
(0.0–105.0)
221.3
(52.5–570.0)
0.0
(0.0–0.0)

p valuea

Duration—min/
week, median
(IQR)

0.502

0
(0.0–20.0)
< 0.001*
0.0
(0.0–140.0)
< 0.001*
0.0
(0.0–0.0)
0.445

Post-chemotherapy (N = 37)b

During chemotherapy

0.0
(0.0–87.5)
< 0.001*
180.0
(30.0–540.0)
1.000
0.0
(0.0–0.0)

p valuea

Duration—min/
week, median
(IQR)

0.947

0.0
(0.0–20.0)
0.010*
120.0
(25.0–187.5)
< 0.001*
0.0
(0.0–0.0)
0.321

0.0
(0.0–100.0)
0.010*
220.0
(20.0–455.0)
1.000
0.0
(0.0–0.0)

p valuea

0.275
0.297
0.539

0.953
0.017*
1.000

p values based on Wilcoxon signed rank test with pre-diagnosis value for each intensity level as the reference group
Post-chemotherapy data is only available for participants who completed chemotherapy at the time of study participation (N = 37)
p value < 0.05
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was also associated with statistically significant decreases
in moderate-intensity physical activity; the median (IQR)
decreased from 420 (140.0–840.0) to 221 (52.5–570.0)
min/week (p < 0.001). This decrease was sustained during
chemotherapy (p = 0.010) and, among the subset who had
completed chemotherapy, after chemotherapy completion
as well (p = 0.017). Across all time periods, light and moderate physical activity were more commonly reported than
light and moderate exercise. Walking was the most common
exercise modality reported across the cancer-related time
periods (Table 4).

Perceived exercise barriers and facilitators
The most commonly reported barriers to exercise include
adverse effects from treatment (52.0%), lack of self-discipline (32.4%), weather (43.1%), and other health issues
(27.5%) (Table 5). The most commonly reported facilitators
to exercise include the desire to remain healthy and productive (84.3%), to improve sleep and mental well-being
(72.5%), encouraged by family and friends (52.0%), having exercised prior to treatment with a desire to maintain
this activity (50%), increase confidence (50%), help cope
better with cancer treatment and side effects of the treatment (48%), and to improve independence and self-control
(47.1%) (Table 5). No significant differences in facilitators
or barriers were observed between participants undergoing
chemotherapy and those who had completed chemotherapy.

Table 4  Moderate and vigorous
exercise modalities reported by
study participants as free-text
across 3 cancer-related time
periods (N = 102)

Before diagnosis
Activity type

N (%)

Moderate exercise types reported
Walk
37 (36.3)
Jog/run
15 (14.7)
Cycle
6 (5.9)
Gym/physical training 6 (5.9)
Sports
4 (3.9)
Aerobics (unspecified) 3 (2.9)
Swim
3 (2.9)
Yoga
2 (2.0)
4 (3.9)
Othera
Vigorous exercise types reported
Gym/physical training 11 (10.8)
Jog/run
7 (6.9)
Swim
9 (8.8)
6 (5.9)
Otherb
a
b

Exercise guidance and education
Most respondents reported receiving information about
cancer and exercise (73.5%; n = 75/102), primarily from
HCPs (e.g., oncologists, physiotherapists, social workers)
(73.3%; n = 55/75) (Fig. 1). Of the 47 participants (46.1%;
n = 47/102) who reported having been advised to perform
exercise by healthcare or fitness professionals following
cancer diagnosis, all reported they believed exercise would
be beneficial to their health and wellbeing prior to receiving guidance. Thirty-four of those participants (72.3%;
n = 34/47) reported the advice received had been adequate
in getting them to start exercising. Fifty participants (49%;
n = 50/102) expressed interest in the proposed investigatordesigned exercise program.

Discussion
Physical activity and exercise behavior of cancer survivors at
NCCS were examined across the continuum of survivorship,
and perceived barriers and facilitators to exercise (i.e., purposeful, prescriptive, programmed, and progressive activities targeting various bodily systems [28]) were described.
Surprisingly, a large proportion of survivors in this cohort
met the aerobic exercise NCCN guidelines prior to cancer
diagnosis. This finding is distinct from observations among
previous survivor populations in the USA, Canada, Germany, and Korea [4, 19, 21, 30–32], and is reflective of the
generally healthy BMIs reported in this cohort, as well as
After diagnosis, before treatment

During chemotherapy

Activity type

N (%)

Activity type

N (%)

Walk
Jog/run
Cycle
Gym/physical training
Sports
Aerobics (unspecified)
Swim
Yoga
Other

29 (28.4)
4 (3.9)
3 (2.9)
2 (2.0)
1 (1.0)
2 (2.0)
0 (0.0)
0 (0.0)
2 (2.0)

Walk
Jog/run
Cycle
Gym/physical training
Sports
Aerobics (unspecified)
Swim
Yoga
Other

35 (34.3)
2 (2.0)
2 (2.0)
3 (2.9)
1 (1.0)
4 (3.9)
0 (0.0)
0 (0.0)
0 (0.0)

Gym/physical Training
Jog/run
Swim
Other

3 (2.9)
1 (1.0)
1 (1.0)
3 (2.9)

Gym/physical training
Jog/run
Swim
Other

0 (0.0)
1 (1.0)
1 (1.0)
2 (2.0)

Includes pilates (n = 1), trek (n = 1), calisthenics (n = 1), and Zumba (n = 1)

Includes basketball (n = 1), boxing (n = 1), calisthenics (n = 1), taekwondo (n = 1), trek (n = 1), and mountain biking (n = 1)
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Table 5  Perceived facilitators and barriers to exercise among study participants
Facilitators
Personal
Remain healthy and productive
Improve sleep and mental well-being
Exercised prior to treatment with a desire to maintain this activity
Increase confidence
Cope better with cancer treatment and side effects from treatment
Improve independence and self-control
Reduce adverse effects from treatment
Positive experience with exercise prior to treatment
Prevent cancer recurrence
Encouragement
Sufficient time
Social
Interactions with other cancer patients through exercise
programs
Environmental
Encouraged by family and friends to exercise
Encouraged by healthcare professionals to exercise
Accessible programs tailored to cancer patients
Barriers
Personal
Adverse effects from treatment (e.g., lack of energy, fatigue,
numbness, tingling, muscle weakness, pain, depression, anxiety, limited joint movement, vomiting)
Lack of self-discipline
Exercise limited by other health issues
Fear of injury
Lack of time
Exercise is not a priority (e.g., work/family responsibilities)
Lack of interest in exercise
Exercise is not in routine
Inconvenient exercise schedule
Uncertainty in use of fitness equipment and type of appropriate exercises
Unawareness of the need to exercise
Exercise will make the cancer progress further
Social
Lack of company
Environmental
Weather (e.g., wet, warm, windy)
Cost of exercising
Lack of access to training facility or equipment
Lack of appropriate exercise facility
Lack of knowledgeable exercise staff
Warned by healthcare professionals not to exercise
Warned by family/friends not to exercise

All survivors
(N = 102)
N (%)

Undergoing chemotherapy Completed chemotherapy p valuea
(n = 37)
(n = 65)
N (%)
N (%)

86 (84.3)
74 (72.5)
51 (50.0)
51 (50.0)
49 (48.0)
48 (47.1)
45 (44.1)
45 (44.1)
40 (39.2)
36 (35.3)
33 (32.4)

57 (87.7)
50 (76.9)
31 (47.7)
30 (46.2)
33 (50.8)
33 (50.8)
29 (44.6)
28 (43.1)
22 (33.8)
21 (32.3)
25 (38.5)

29 (78.4)
24 (64.9)
20 (54.1)
21 (56.8)
16 (43.2)
15 (40.5)
16 (43.2)
17 (45.9)
18 (48.6)
15 (40.5)
8 (21.6)

0.261
0.249
0.681
0.410
0.539
0.410
1.000
0.837
0.205
0.518
0.123

34 (33.3)

21 (32.3)

13 (35.1)

0.829

53 (52.0)
45 (44.1)
37 (36.3)
All survivors
(N = 102)
N (%)

32 (49.2)
25 (38.5)
23 (35.4)
Undergoing chemotherapy
(N = 65)

21 (56.8)
20 (54.1)
14 (37.8)
Completed chemotherapy
(n = 37)

0.539
0.150
0.833
p valuea

53 (52.0)

30 (46.2)

23 (62.2)

0.150

33 (32.4)
28 (27.5)
22 (21.6)
21 (20.6)
20 (19.6)
18 (17.6)
17 (16.7)
11 (10.8)
10 (9.8)

19 (29.2)
17 (26.2)
15 (23.1)
17 (26.2)
15 (23.1)
9 (13.8)
12 (18.5)
9 (13.8)
6 (9.2)

14 (37.8)
11 (29.7)
7 (18.9)
4 (10.8)
5 (13.5)
9 (24.3)
5 (13.5)
2 (5.4)
4 (10.8)

0.387
0.818
0.803
0.078
0.305
0.279
0.591
0.320
1.000

6 (5.9)
2 (2.0)

6 (9.2)
2 (3.1)

0 (0.0)
0 (0.0)

0.084
0.533

23 (22.5)

12 (18.5)

11 (29.7)

0.222

44 (43.1)
16 (15.7)
11 (10.8)
10 (9.8)
10 (9.8)
7 (6.9)
4 (3.9)

27 (41.5)
12 (18.5)
6 (9.2)
6 (9.2)
6 (9.2)
5 (7.7)
3 (4.6)

17 (45.9)
4 (10.8)
5 (13.5)
4 (10.8)
4 (10.8)
2 (5.4)
1 (2.7)

0.683
0.401
0.522
1.000
1.000
1.000
1.000

a 2

χ test was used to test for associations between chemotherapy completion and barriers; Fisher’s exact test was utilized when cell counts < 5
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the high levels of societal physical activity described in Singapore’s National Health Survey (NHS). Limited existing
investigations into patterns of physical activity in Singapore
have shown travel-related activity to be a large contributor
to physical activity, which could be related to Singapore’s
unique public transportation infrastructure and high taxes
on private car ownership [33]. Cultural differences may also
have influenced the comparatively high physical activity
levels observed in this Singapore survivor cohort; however,
further research is still greatly needed. In line with previous
investigations [21, 30, 31, 34–36], the point of diagnosis
remained a marker for the significant decline in both incidental physical activity and purposeful exercise. Therefore,
even among this notably active cohort of survivors, opportunities for increased engagement in exercise throughout the
survivorship continuum remain. Additionally, the point of
diagnosis could serve as a key moment for the initiation of
discussion regarding exercise.
As seen in previous investigations, the most commonly
reported barrier to exercise was adverse effects from treatment, which encompassed a range of symptoms such as
fatigue, muscle weakness, and pain (Table 5) [22, 37]. However, despite guidelines recommending the utilization of
exercise to reduce cancer treatment-related sequelae [5–7],
less than half of participants reported reductions in adverse
events from treatment as a facilitator of exercise. These findings suggest a lack of education among Singaporean cancer
survivors regarding the benefits of exercise that has been
similarly observed in international investigations [22, 37].
This is further supported by the finding that less than half of
participants reported having been directly advised to engage
in exercise following their cancer diagnosis. Therefore, the
effective implementation of an exercise intervention at the
NCCS for cancer survivors will require evidence-based
educational components to motivate and guide engagement.
Optimistically, participant survey responses were generally
reflective of positive perceptions of exercise and a receptiveness to exercise guidance. Less than one-fifth of participants
reported a lack of interest in exercise and exercise not being
a priority as barriers to exercise engagement, and the majority of participants reported facilitators such as the desire to
remain healthy and productive and previous participation in
exercise as facilitators. Additionally, contrary to previous
investigations [22], only 20.6% of participants noted a lack
of time as a barrier, suggesting a previously identified key
barrier to engagement may be less prominent among this
cohort. Further, 72% (34/47) of participants who reported
having been advised to exercise after cancer diagnosis
reported that the advice was adequate in getting them to
initiate exercise. Overall, these findings are supportive of the
positive reception of exercise education and an appropriately
designed and promoted exercise intervention for survivors
at the NCCS.
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In line with previous studies, walking was the most
reported activity among participants [22–24, 38]. Although
walking is an aerobic exercise activity, to maximize the benefits of exercise among cancer survivors and meet all components of the NCCN exercise guidelines, Singaporean cancer
survivors must prioritize participation in resistance training
activities. Resistance training, defined as muscle strengthening and muscle building exercises, is key for addressing
important cancer-related side effects including bone and
muscle loss, fragility, loss of physical function, and fall prevention, especially among metastatic cancer survivors who
compose two-thirds of this study population [12, 13, 39–41].
Survivors with metastases have previously reported hesitancy to conduct exercise, particularly resistance training,
without supervision due to issues including fear of fracture,
bone metastases, and fragility [6, 7, 15, 42–44]. With 21.6%
of cancer survivors reporting fear of injury as a barrier to
exercise and an overwhelming majority engaging primarily
in walking, individualized guidance and education regarding
the appropriate and safe engagement in resistance training
will be needed at the NCCS to optimize the benefits of exercise among survivors.
Although the necessity of survivor education regarding
the benefits of exercise has been highlighted in this investigation, significant barriers to oncologist exercise promotion have been identified in literature that will require consideration during implementation at the NCCS. Oncologist
lack of time and lack of knowledge regarding exercise and
cancer survivorship [18] will likely be influential in Singapore where the oncologist-centric model of cancer care has
historically placed the burden of addressing complex survivorship needs on the oncologists [13, 18, 26]. Therefore, not
only is oncologist education regarding exercise guidelines
for cancer survivors recommended, but multidisciplinary
team support would be as well. Pilot studies examining the
feasibility and acceptability of survivor-specific exercise
intervention programs in other international cohorts have
seen low referral and participation rates [40, 41, 45]. Filling
the research-to-practice gap in Singapore exercise oncology
and successfully integrating exercise into standard oncology
care will further require the development of intentionally
designed, standardized care pathways and implementation
plans involving multidisciplinary team support [40, 41, 45].
The findings of this investigation should be interpreted
with cautions. Physical activity and exercise are selfreported and subject to recall bias. Additionally, variability
in the ability to recall based on the time since completion
of each survivorship stage is likely reflected in these findings. The survey tool utilized to capture physical activity and
exercise data was an investigator-developed, non-validated
tool and thus not confirmed to be psychometrically sound.
Additionally, given that resistance training is often poorly
understood by cancer survivors and difficult to accurately
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capture through self-reported survey, only the formal assessment of aerobic exercise NCCN guideline adherence, and
not resistance training guideline adherence, was conducted.
However, all exercise types engaged were collected in freeform text as seen in Table 4. Further, the findings of this
study did not control for the recency of treatments including
surgery and radiation, which would likely influence reported
exercise behavior. Additionally, given that only 50.5% of
approached patients consented to participate in the study,
the findings could be susceptible to sampling bias. Finally,
participants were largely active prior to cancer diagnosis,
viewed exercise in a positive light, were diagnosed with
stage IV cancer, and therefore the findings should be interpreted within that context.

Conclusion
This is the first study investigating exercise activity, barriers, and facilitators among cancer survivors at NCCS, which
is the largest ambulatory cancer center in Singapore. This
study outlined necessity of increased exercise engagement
following cancer diagnosis, the necessity of increased exercise education among survivors, outlined barriers and facilitators to exercise engagement, and revealed walking as the
primarily exercise modality among survivors. The findings
of this study provide vital preliminary data that can serve
both in supporting and in informing the design of survivorspecific exercise interventions that can be integrated into
Singapore’s health care infrastructure at the NCCS in order
to maximize the benefits of exercise among survivors.
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